FDA Warns of Higher Death Risk With Pepaxto in Multiple Myeloma ...Middle East

Following an accelerated approval earlier this year, analysis of data from an ongoing confirmatory trial has shown an increased risk of death with melphalan flufenamide (Pepaxto). Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Warns of Higher Death Risk With Pepaxto in Multiple Myeloma )

Also on site :

• Kremlin reveals how Putin will take part in BRICS summit
• Author Gets Honest About LeBron James, Michael Jordan's Legacy in New Book
• Faith leaders challenge Texas law requiring Ten Commandments in classrooms